Potthoff, A.-L.; Heiland, D.H.; Evert, B.O.; Almeida, F.R.; Behringer, S.P.; Dolf, A.; Güresir, Á.; Güresir, E.; Joseph, K.; Pietsch, T.;
et al. Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide. Cancers 2019, 11, 858.
https://doi.org/10.3390/cancers11060858
AMA Style
Potthoff A-L, Heiland DH, Evert BO, Almeida FR, Behringer SP, Dolf A, Güresir Á, Güresir E, Joseph K, Pietsch T,
et al. Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide. Cancers. 2019; 11(6):858.
https://doi.org/10.3390/cancers11060858
Chicago/Turabian Style
Potthoff, Anna-Laura, Dieter Henrik Heiland, Bernd O. Evert, Filipe Rodrigues Almeida, Simon P. Behringer, Andreas Dolf, Ági Güresir, Erdem Güresir, Kevin Joseph, Torsten Pietsch,
and et al. 2019. "Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide" Cancers 11, no. 6: 858.
https://doi.org/10.3390/cancers11060858
APA Style
Potthoff, A.-L., Heiland, D. H., Evert, B. O., Almeida, F. R., Behringer, S. P., Dolf, A., Güresir, Á., Güresir, E., Joseph, K., Pietsch, T., Schuss, P., Herrlinger, U., Westhoff, M.-A., Vatter, H., Waha, A., & Schneider, M.
(2019). Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide. Cancers, 11(6), 858.
https://doi.org/10.3390/cancers11060858